Company CVR Medical Corp. BOERSE MUENCHEN
Equities
B3BN
CA1266321084
Biotechnology & Medical Research
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 EUR | -9.09% |
|
-9.09% | -42.31% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Rhodes
CEO | Chief Executive Officer | - | 21-01-19 |
Paul S. Blunden
PSD | President | - | 16-10-19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul S. Blunden
PSD | President | - | 16-10-19 |
Phillip Bendick
BRD | Director/Board Member | - | 20-02-12 |
Joseph Lynch
BRD | Director/Board Member | - | 20-02-16 |
Trish Howell
BRD | Director/Board Member | - | 20-03-08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 107,233,206 | 93,517,112 ( 87.21 %) | 0 | 87.21 % |
Company contact information
CVR Medical Corp.
221 West Esplanade Suite 409
V7M 3J3, North Vancouver
+757-909-0491
http://www.cvrmed.com![address CVR Medical Corp.(B3BN)](https://cdn.zonebourse.com/static/address/120379844.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-34.72% | 8.68B | |
+23.07% | 3.86B | |
+12.30% | 2.43B | |
-26.46% | 1.84B | |
-10.94% | 1.73B | |
+37.10% | 1.16B | |
+51.25% | 842M | |
-9.17% | 702M | |
-11.12% | 594M |
- Stock Market
- Equities
- CVM.H Stock
- B3BN Stock
- Company CVR Medical Corp.